Article info
Therapeutics/Prevention
Randomised controlled trial
High-sensitivity troponin predicts coronary disease outcomes in type 2 diabetes but yields no benefit in selecting patients for revascularisation
- Correspondence to : Dr Juhani Junttila, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, PO Box 5000, Oulu 90014, Finland; juhani.junttila{at}oulu.fi
Citation
High-sensitivity troponin predicts coronary disease outcomes in type 2 diabetes but yields no benefit in selecting patients for revascularisation
Publication history
- First published April 13, 2016.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/